As they embarked on an upcoming rare disease clinical trial, a mid-sized biopharmaceutical company was struggling with patient recruitment and site selection. The company needed to identify sites with the greatest access to patients and highest enrollment performance but did not have deep enough data to make confident decisions. See how Medidata AI Intelligent Trials helped solve the site challenge.

A sponsor is on a mission to conquer cancer with data, empowering patients and providers to act decisively in fighting the disease. Shortly after the sponsor became publicly traded, the company planned to sponsor its first large clinical trial. Recognizing that the financial management of the study would be as critical to the trial’s success as data management, the sponsor turned to Medidata’s Rave Site Payments solution to track and manage timely payments to research sites, triggered by entries in Medidata’s Rave EDC (Electronic Data Capture) solution.

A top 10 biopharmaceutical company was looking to gain agility and confidence in their trial planning, site selection, and enrollment decisions in a priority indication. The sponsor wanted to expand their site list and gain a deeper understanding of how existing sites in their database performed.

A global life sciences organization engaged in an initiative to significantly improve clinical productivity. This industry leader typically has hundreds of new treatments in development at a time in all trial phases. The capture, triage and reporting of serious adverse events (SAEs) by local and central pharmacovigilance (PV) groups is a critical process that runs concurrently with data management.